In addition to the pro-angiogenic effect, we found that adrenomedullin also suppressed the formation of endothelial CCL2 through cAMP-PKA, and thereby resulted in the suppression of CCL2-induced inhibition of adrenomedullin formation by tumor cells. The gene discussed is ADM; the disease is neoplasm.